Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003

Brady S. Laughlin, Cameron S. Thorpe, Todd A. DeWees, Molly M. Voss, John H. Chang, William F. Hartsell, Christopher C. Sinesi, Jean Claude M. Rwigema, Sameer R. Keole, Vinai Gondi, Carlos E. Vargas

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003'. Together they form a unique fingerprint.

Medicine & Life Sciences